PPIO-007 Correlation Analysis of Type II Diabetes Mellitus on Short-term and Long-term Outcomes of Patients With Esophageal Squamous Cell Cancer Undergoing Minimally Invasive Esophagectomy
Conditions: Esophageal Squamous Cell Carcinoma; Surgery Interventions: Other: Whether there is type 2 diabetes mellitus before surgery Sponsors: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials

Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: Sacituzumab govitecan Sponsors: National Taiwan University Hospital; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials

Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal Carcinoma
Conditions: Dysphagia Interventions: Device: Intermittent Oral-esophageal Tube Feeding; Device: Nasogastric Tube Feeding; Behavioral: comprehensive rehabilitation therapy Sponsors: Copka Sonpashan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib in Combination With Trastuzumab Deruxtecan or With Trastuzumab Emtansine and to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Conditions: Metastatic Breast Cancer; Metastatic Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Esophageal Adenocarcinoma Interventions: Drug: Zongertinib; Drug: Trastuzumab deruxtecan; Drug: Trastuzumab emtansine Sponsors: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials

BReath Hold TecHniquEs for Radiotherapy of Esophageal Carcinoma
Conditions: Esophageal Cancer Interventions: Other: DIBH using ABC technique; Other: DIBH using VC technique Sponsors: University Medical Center Groningen Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials

Influence of Nutrition and Sarcopenia on Esophageal Cancer Outcomes
Conditions: Esophageal Cancer; Sarcopenia Sponsors: Benaroya Research Institute; Imperial College London Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials

Preoperative Arterial Embolization Before Oncologic Esophagectomy as a Technique for Ischemic Gastric Conditioning
Conditions: Esophageal Cancer Interventions: Other: Collecting data from the medical record Sponsors: Centre Hospitalier Universitaire de Saint Etienne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials

Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer
Conditions: Esophageal Cancer; Gastric Cancer; Precision Screening; Sequential Screening; Risk Stratification Interventions: Procedure: Risk Assessment and Individualized Surveillance; Procedure: Universal screening Sponsors: Peking University Cancer Hospital& Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials

Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Cancer Interventions: Drug: Combination of pembrolizumab and platinum containing dual drugs Sponsors: Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials

Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: paclitaxel; Drug: carboplatin; Drug: tislelizumab; Radiation: radiotherapy Sponsors: Qiu Guoqin Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: BL-B01D1; Drug: Irinotecan; Drug: paclitaxel; Drug: docetaxel Sponsors: Sichuan Baili Pharmaceutical Co., Ltd.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

A Single Arm, Single Center, Phase II Clinical Study of Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Cancer Interventions: Drug: Combination of pembrolizumab and platinum containing dual drugs Sponsors: Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

Profiling Microbiome Associated Metabolic Pathways in oesophageaL cancEr Survivors
Conditions: Oesophageal Cancer; Quality of Life; Bacterial Overgrowth Interventions: Diagnostic Test: Breath test; Diagnostic Test: Saliva sample; Diagnostic Test: Blood sample; Diagnostic Test: Urine sample; Diagnostic Test: Stool sample; Diagnostic Test: Health-related Quality of life questionnaires Sponsors: Imperial College London; Imperial College Healthcare NHS Trust; West Hertfordshire Teaching Hospitals NHS Trust; Barking, Havering and Redbridge University Hospitals NHS Trust Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

Effect of Oral Enteral Nutrition in Nasopharyngeal Carcinoma Survivors With Swallowing Disorders
Conditions: Dysphagia Interventions: Device: Nasogastric Tube Feeding; Device: Intermittent Oral-esophageal Tube Feeding; Behavioral: comprehensive rehabilitation therapy Sponsors: Muhammad Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

Oral Enteral Nutrition in Delayed Onset Radiotherapy-related Swallowing Disorder in Nasopharyngeal Carcinoma
Conditions: Dysphagia Interventions: Device: Intermittent Oral-esophageal Tube Feeding; Device: nasogastric tube feeding Sponsors: Muhammad Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials